在“Elsevier电子期刊”中,命中:2条,耗时:0.033982 秒

在所有数据库中总计命中:81

1.Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study
1
按检索点细分(2)
作者(2)
按出版年细分(2)
2017年(2)
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.